Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Liraglutide Injection Marks Debut as First Authorized Generic GLP-1 Product In late June, Teva Pharmaceuticals launched the first generic GLP-1 (Glucagon-Like-Peptide-1) receptor agonist in the United States, known as Liraglutide injection (6 mg/mL)
Weight loss continued throughout the full 48-week treatment period
ROS accumulation mediated by FGF23 worsens Ca 2+ influx and PS exposure, thereby promoting faster erythrocyte removal (Mehta et al., 2017)
Various animal-based studies examining the hypoglycemic effects of Human Growth Hormone (hGH) have shown that the C-terminus of the peptide is responsible for its ability to lower blood sugar
US$ 20.75
US$ 23.75
US$ 24.80
US$ 28.62
US$ 26.20
US$ 25.76
US$ 23.57
US$ 24.16
US$ 25.29
